Silver Book Fact

Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar, David, and Gregory Samsa
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Disease specific status and generic health status improvements from TAVR and SAVR
    Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate risk symptomatic aortic stenosis (SAS) patients were associated with significant improvements in disease specific status (16 to…  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…  
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…